Immunomodulatory role of Nanocurcumin in COVID-19 patients with dropped natural killer cells frequency and function.

MLA

Abbaspour-Aghdam, Sanaz, et al. “Immunomodulatory Role of Nanocurcumin in COVID-19 Patients with Dropped Natural Killer Cells Frequency and Function.” European Journal of Pharmacology, vol. 933, Oct. 2022, p. 175267. EBSCOhost, https://doi.org/10.1016/j.ejphar.2022.175267.

APA

Abbaspour-Aghdam, S., Hazrati, A., Abdolmohammadi-Vahid, S., Tahmasebi, S., Mohseni, J., Valizadeh, H., Nadiri, M., Mikaeili, H., Sadeghi, A., Yousefi, M., Roshangar, L., Nikzad, B., Jadidi-Niaragh, F., Kafil, H. S., Malekpour, K., & Ahmadi, M. (2022). Immunomodulatory role of Nanocurcumin in COVID-19 patients with dropped natural killer cells frequency and function. European Journal of Pharmacology, 933, 175267. https://doi.org/10.1016/j.ejphar.2022.175267

Chicago

Abbaspour-Aghdam, Sanaz, Ali Hazrati, Samaneh Abdolmohammadi-Vahid, Safa Tahmasebi, Jafar Mohseni, Hamed Valizadeh, Mehdi Nadiri, et al. 2022. “Immunomodulatory Role of Nanocurcumin in COVID-19 Patients with Dropped Natural Killer Cells Frequency and Function.” European Journal of Pharmacology 933 (October): 175267. doi:10.1016/j.ejphar.2022.175267.